Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Third Military Medical University
Age
30–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, aged between 30-60 years old.
Patients with poorly controlled hypertension (office blood pressure ≥130/80 mmHg) with rational lifestyle change and triple antihypertensive drugs (irbesartanhydrochlorothiazide 162.5 mg/d, amlodipine 5 mg/d) for at least 2 weeks
Positional blood aldosterone ≥100pg/ml.
Informed consent signed and agreed to participate in this trial.
You may not be if
Hyperkalemia or hypokalemia.
Secondary hypertension.
History of depression, schizophrenia or vascular dementia.
Renal failure or the following history of nephropathy: serum creatinine 1.5 times higher than the upper limit; dialysis history; or nephrotic syndrome.
Adrenergic insufficiency.
Heart failure with NYHA grade Ⅱ-Ⅳ grade or unstable angina, severe cardiovascular and cerebrovascular stenosis, myocardial infarction, intracranial aneurysm, stroke and other acute cardiovascular events.
Acute infections, tumors and severe arrhythmias, psychiatric disorders,
drugs or alcohol addicts.
Liver dysfunction or the following history of liver disease: AST or ALT 3 times higher than the upper limit, liver cirrhosis, history of hepatic encephalopathy, esophageal variceal history or portal shunt history.
Fertile woman without contraceptives.
Coagulation dysfunction.
Pregnant women or lactating women.
Participated in other clinical trials or admitted with other research drugs within 3 months prior to the trial.
Any surgical or medical condition which can significantly alter the absorption, distribution, metabolism, or excretion of any study drug.
Allergy or any contraindications for the study drugs, contrast agents and alcohol.
Refused to sign informed consent
Clareo Health | Adrenal Artery Ablation for Uncontrolled Hypertension
